Forian (FORA) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
4 Dec, 2025Executive summary
A special meeting is scheduled for January 8, 2026, to vote on redomiciling from Delaware to Maryland and to approve potential adjournments if more proxy votes are needed.
The redomiciliation is intended to facilitate consideration of a take-private offer and other strategic alternatives, removing Delaware's Section 203 anti-takeover restrictions.
The Board, following a Special Committee's recommendation, unanimously supports the redomiciliation and related proposals.
The Consortium, holding 66.5% of shares, has indicated support for both proposals, ensuring their approval.
Voting matters and shareholder proposals
Proposal 1 seeks approval to redomicile to Maryland via statutory conversion.
Proposal 2 allows adjournment of the meeting to solicit more proxies if needed for Proposal 1.
The Board recommends voting "FOR" both proposals.
Shareholders can vote online, by phone, mail, or during the virtual meeting.
Shareholder proposals for the 2026 annual meeting must be submitted between December 30, 2025, and January 29, 2026.
Board of directors and corporate governance
The Board is classified into three classes with staggered three-year terms.
The Maryland Charter will allow up to 15 directors, with vacancies filled by the Board.
Directors can be removed only for cause by a majority vote.
The Special Committee, composed of independent directors, led the evaluation of the redomiciliation and strategic alternatives.
Latest events from Forian
- Q2 revenue fell 2% to $4.8M, net loss widened, and 2024 guidance was lowered.FORA
Q2 20241 Feb 2026 - Q3 2024 revenue fell 12% to $4.7M; Kyber acquisition and sales momentum set up future growth.FORA
Q3 202414 Jan 2026 - Re-domiciliation from Delaware to Maryland approved by majority stockholder vote.FORA
EGM 20268 Jan 2026 - Stockholders to vote on redomiciling to Maryland, enabling a take-private offer and strategic flexibility.FORA
Proxy Filing15 Dec 2025 - Annual meeting to vote on director elections, equity plan expansion, and auditor ratification.FORA
Proxy Filing1 Dec 2025 - Key votes include director elections, equity plan expansion, and auditor ratification.FORA
Proxy Filing1 Dec 2025 - Q1 2025 revenue up 45% to $7.1M, with narrowed net loss and strong 2025 growth outlook.FORA
Q1 202526 Nov 2025 - Q2 2025 revenue up 57% to $7.5M, with positive net income and strong outlook for 2025.FORA
Q2 202523 Nov 2025 - Q3 2025 revenue surged 66% to $7.8M, with improved margins and strong year-end outlook.FORA
Q3 202517 Nov 2025